XASX
HM1
Market cap459mUSD
Oct 09, Last price
2.85AUD
1D
-1.04%
1Q
-4.68%
IPO
10.04%
Name
Hearts and Minds Investments Ltd
Chart & performance
P/E
14.07
P/S
7.62
EPS
0.20
Div yield, %
8.68%
Shrs. gr., 5y
0.33%
Rev. gr., 5y
103.34%
Revenues
86m
-48.13%
Net income
46m
-56.59%
CFO
-13m
L+414.51%
Dividend
Sep 09, 20260.1 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hearts and Minds Investments Limited (HM1.AX) operates as an Australian listed investment company with a dual objective: to assemble a focused investment portfolio comprising the most compelling ideas from various fund managers, and simultaneously to contribute to Australian medical research initiatives. The company aims to offer shareholders an investment opportunity through a tightly concentrated portfolio of approximately 25 to 30 long positions in both Australian and international public equities, selected based on their highest conviction. Approximately 35% of its investment capital is allocated following the annual recommendations put forth by fund managers who speak at the Sohn Hearts & Minds Investment Leaders Conference, known as 'Conference Fund Managers'. The remaining 65% of the portfolio is guided by the strongest ideas from a group of six designated 'Core Fund Managers', which prominently include Caledonia (Private) Investments, Cooper Investors, and Magellan Asset Management, among others.
Key people
Independent Chairman of the Board · since 2018
Chief Executive Officer · since 2025
Charlie Lanchester
Chief Investment Officer · since 2023
Natalie Climo
Company Secretary · since 2025
Independent Director
Guy Fowler
Independent Director
Matthew Grounds
Independent Director
Michael Traill
Independent Director
Independent Director
Independent Director
David Wright
Independent Director
IPO date
Nov 14, 2018
Employees
Domiciled in
AU
Incorporated in
AU
Legal address
Level 12
225 George Street
Sydney, NSW 2000
AU
225 George Street
Sydney, NSW 2000
AU
Headquarters
Chifley Plaza
2 Chifley Square
Sydney, NSW 2000
AU
2 Chifley Square
Sydney, NSW 2000
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑10 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||